Salute e Benessere

RevitaLash® Cosmetics Announces New Milestone of Over $9 Million Committed to…

As part of its ongoing Eternally Pink® pledge, RevitaLash Cosmetics continues its year-round philanthropic mission by donating a portion of proceeds from every product sold to directly fund groundbreaking research and make lifesaving care accessible to more patients. As part of its ongoing Eternally Pink® pledge, RevitaLash Cosmetics continues its year-round philanthropic mission by donating a portion of proceeds from every product sold to directly fund groundbreaking research and make...
PR Newswire
01/10/2024

Auto Depth Digital Wound Measurement Now Available on MolecuLightDX

Standard of care depth measurements, made using a probe and ruler, are often inaccurate with a high degree of variability in measured depths across different clinicians, usually resulting in overestimation. The new MolecuLightDX Auto Depth feature will help to standardize wound measurement across multiple providers. This new feature has been extensively tested and validated to ensure exceptional accuracy and robust reliability within a real clinical environment on real patient wounds…
PR Newswire
01/10/2024

BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day

Provides updates on BioNTech's strategy to scale and deploy AI-capabilities across the immunotherapy pipelineHighlights InstaDeep's new near exascale supercomputer, Kyber, with the aim of enabling BioNTech to compute at scaleUnveils novel AI Bayesian Flow Network (“BFN”) models for protein sequence generationHighlights progress in deploying AI across BioNTech's immunotherapy pipeline, including in immunohistochemistry, DNA/RNA sequencing, proteomics, protein design, and lab...
Nasdaq GlobeNewswire
01/10/2024

Responding to spine surgeons' educational needs, AO Spine rolls out new…

Each course addresses selected, standardized learning objectives, based on the AO Spine Curriculum, ensuring AO Spine quality standards are met for each participant, no matter where they decide to attend the course. Each course addresses selected, standardized learning objectives, based on the AO Spine Curriculum, ensuring AO Spine quality standards are met for each participant, no matter where they decide to attend the course. The new courses offer participants a unique pathway to surgical...
PR Newswire
01/10/2024

Relu Secures FDA 510(k) and CE Marking for Revolutionary Dental Software Relu®…

FDA clearance signifies compliance with U.S. medical device standards, while the CE Mark confirms adherence to EU regulations for product safety and consumer protection. This dual recognition underscores Relu's commitment to excellence in the oral health sector. "We are thrilled to have attained both FDA and CE approval for the Relu® Creator," statedAdriaan Van Gerven, CTO and Co-founder, of Relu. "These significant achievements are a testament to Relu's dedication to creating...
PR Newswire
01/10/2024

AstronauTx appoints Jane Rhodes as Chief Executive Officer and Expands Executive…

A neuroscientist by training, Jane began her career in the field of discovery research and worked on novel therapies for Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), stroke and multiple sclerosis (MS). She has contributed to the development and launch of several marketed products for neurological indications over the span of her career. A neuroscientist by training, Jane began her career in the field of discovery research and worked on novel therapies for...
PR Newswire
01/10/2024

Resolution Therapeutics Announces Upcoming Presentations at the American…

EDINBURGH, Scotland and LONDON, Oct. 1, 2024 Resolution Therapeutics Limited ("Resolution" or "Company"), a clinical-stage biopharmaceutical company focused on unlocking the regenerative potential of macrophage therapy for the treatment of inflammatory and fibrotic diseases, today announces two abstracts have been selected for presentations at the American Association for the Study of Liver Disease (AASLD) The Liver Meeting® 2024. The conference will take place in San Diego…
PR Newswire
01/10/2024

Implantica welcomes 23 top anti-reflux surgeons from 17 leading centers in the…

Dr. med. Jörg Zehetner, a leading anti-reflux surgeon from Switzerland with about 150 RefluxStop procedures completed, led this training. He says, "I was honored to lead the RefluxStop training in Spain where I have visited and proctored most of the RefluxStop Surgeons over the past 1.5 years. The atmosphere in this meeting was phenomenal as the Spanish surgeons discussed the promising outcomes of RefluxStop experienced in their own practice. Since RefluxStop does not encircle the food…
PR Newswire
01/10/2024

Neuraxpharm expands operations into the Middle East

Neuraxpharm's move into the Middle East follows the opening of affiliates in Brazil and Mexico in 2023 and adds to the growing list of more than 20 European countries where the Company is now established alongside its global network of distributors. Neuraxpharm's move into theMiddle Eastfollows the opening of affiliates inBrazilandMexicoin 2023 and adds to the growing list of more than 20 European countries where the Company is now established alongside its global network of distributors...
PR Newswire
01/10/2024

Vivoryon Therapeutics N.V. Shares Highlights from Virtual Kidney Disease KOL…

Halle (Saale) / Munich, Germany, October 1, 2024– Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon ), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the activity and stability of pathologically altered proteins, today announced key takeaways from its virtual Kidney Disease Key Opinion Leader (KOL) Event held September 30, 2024. The event focused on the standard of care and existing medical need, market...
Nasdaq GlobeNewswire
01/10/2024

Santhera Announces Positive Topline Results from LIONHEART Study with AGAMREE®…

Pratteln, Switzerland, October 1, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces the positive outcome of the LIONHEART study, confirming vamorolone's distinctive action also as a mineralocorticoid receptor antagonist, setting it apart from other corticosteroids. The LIONHEART study, an open-label randomized, placebo- and eplerenone-controlled study involving 30 healthy adult male subjects, met its primary endpoint. It demonstrated a statistically significant increase in the urinary...
Nasdaq GlobeNewswire
01/10/2024

Goldgenie Unveils the Ultimate in Tech Luxury: 24k Gold M3 iMac Secures Orders…

One of Goldgenie's prestigious clients includes the Swiss-based interior design firm GRESET REICH, led by established designers and hospitality experts Claudia and Yann Greset. Known for curating exclusive projects for high-net-worth individuals (HNIs) across Europe and beyond, GRESET REICH has successfully brought many hospitality, residential, and corporate projects to life. Recently, Goldgenie provided a limited-edition 24k Gold M3 iMac for one of their undisclosed clients, solidifying their…
PR Newswire
01/10/2024

Sequana Medical announces H1 2024 results and provides business update

PRESS RELEASE REGULATED INFORMATION – INSIDE INFORMATION 30 September 2024, 23:55 CESTSequana Medical announces H1 2024 results and provides business update alfapump® - US FDA approval anticipated Q1 2025 and US launch planned for H2 2025; Strong progress with US reimbursement - CPT III codes issued & NTAP Application filedDSR®– Publication of RED DESERT and SAHARA data in peer-reviewed “European Journal of Heart Failure” highlights potential as...
Nasdaq GlobeNewswire
30/09/2024

SEQUANA MEDICAL ANNOUNCES CONVERTIBLE FINANCING OF UP TO EUR 6.1 MILLION FROM…

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW PRESS RELEASE REGULATED INFORMATION – INSIDE INFORMATION 30 September 2024, 11:55 pm CESTSEQUANA MEDICAL ANNOUNCES CONVERTIBLE FINANCING OF UP TO EUR 6.1 MILLION FROM MAJOR SHAREHOLDERS Continued support from major shareholders – EUR 3...
Nasdaq GlobeNewswire
30/09/2024

Neurocrine Biosciences's Crinecerfont is Set to Transform the Congenital Adrenal…

In the 7MM, the US accounted for the highest prevalent cases of congenital adrenal hyperplasia in 2023, with around 50% of the total prevalent cases across the 7MM; these numbers are expected to increase during the forecast period (2024–2034). In the 7MM, the US accounted for the highest prevalent cases of congenital adrenal hyperplasia in 2023, with around50%of the total prevalent cases across the 7MM; these numbers are expected to increase during the forecast period (2024–2034). ...
PR Newswire
30/09/2024

Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at…

In order to participate, please register in advancehere to obtain a local or toll-free phone number and your personal pin.A live webcast of the call will be available on Teva's website at:https://ir.tevapharm.com/Events-and-Presentations Following the conclusion of the call, a replay of the webcast will be available within 24 hours on Teva's website. About Teva Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a global pharmaceutical leader with a category-defying...
Nasdaq GlobeNewswire
30/09/2024

Galapagos receives transparency notification from EcoR1 Capital

Mechelen, Belgium; 30 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from EcoR1 Capital LLC. Pursuant to Belgian transparency legislation 1, Galapagos received a transparency notification on 26 September 2024 on behalf of Mr. Oleg Nodelman and EcoR1 Capital LLC, who notified us that EcoR1 Capital LLC holds 7,094,049 of Galapagos' voting rights, consisting of 6,939,043 ordinary shares and 155,006 American...
Nasdaq GlobeNewswire
30/09/2024

AB Science announces a slight delay in the publication of its 2024 half-year…

PRESS RELEASEAB SCIENCE ANNOUNCES A SLIGHT DELAY IN THE PUBLICATION OF ITS 2024 HALF-YEAR FINANCIAL REPORTTHE COMPANY WILL PUBLISH ITS HALF-YEAR FINANCIAL REPORT FOR 2024 ON OCTOBER 7, 2024Paris, September 30 2024, 6.30pm CETAB Science SA(Euronext - FR0010557264 - AB) today announced that it has postponed the publication of its financial report for the first half of 2024, initially scheduled for 30 September 2024, to give the auditors time to complete their audit work...
Nasdaq GlobeNewswire
30/09/2024

Casino Group continues its transformation

Casino Group continues its transformationOn 24 April 2024, Casino Group launched a transformation plan to align its organisation with its new scope, centred on convenience retailing.Agreements have been signed with the trade unions in the 7 Group host companies concerned by the employment protection plan, and have been validated by management. Most of the entities concerned have initiated employment protection plans, including voluntary redundancy and in-placement schemes...
Nasdaq GlobeNewswire
30/09/2024

Social support becomes lifeline for health amid financial strain

The report highlights key vitality differences across demographics. Men report higher vitality than women, whose scores have significantly declined since 2023. Among generations, baby boomers have the highest vitality, followed by millennials, and Gen Z, while Gen X reports the lowest score. Millennials also experienced a notable decline in vitality compared to last year. The report highlights key vitality differences across demographics. Men report higher vitality than women, whose scores…
PR Newswire
30/09/2024

Desktop Humidor Market Size to Grow USD 197 Million by 2030 at a CAGR of 4.3% |…

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-6E14235/Global_Desktop_Humidor_Market Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-6E14235/Global_Desktop_Humidor_Market Major Factors Driving the Growth of Desktop Humidor Market The global desktop humidor market is growing as cigar enthusiasts and collectors increasingly prioritize proper cigar storage to maintain quality and freshness. Desktop humidors are specialized containers...
PR Newswire
30/09/2024

Bristol Myers Squibb Marks 10 Years of Global Patient Week with Community…

Commenting on the initiative, Her Highness Sheikha Sheikha Bint Saif Al Nahyan, Chairperson of the Emirates Thalassemia Society, said: "We commend Bristol Myers Squibb for organizing this significant blood donation drive as part of their Global Patient Week. Blood donors play an indispensable role in the fight against thalassemia and other blood disorders. Their generosity not only saves lives but also brings hope and relief to countless families facing the challenges of these conditions…
PR Newswire
30/09/2024

Piramal Pharma Solutions Announces $80M Expansion Plan for Sterile Injectables…

"This expansion represents a strategic investment in the future of Piramal Pharma Ltd. Filling the commercial manufacturing gap enables the Lexington site to access the rapidly expanding injectables market and establish itself as a key player in the segment," said Nandini Piramal, Chairperson, Piramal Pharma Ltd. "This expansion represents a strategic investment in the future of Piramal Pharma Ltd. Filling the commercial manufacturing gap enables theLexingtonsite to access the…
PR Newswire
30/09/2024

Total number of shares and voting rights in Zealand Pharma A/S on September 30…

Company announcement – No. 46 / 2024 Total number of shares and voting rights in Zealand Pharma A/S on September 30, 2024 Copenhagen, Denmark, September 30, 2024–Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Company...
Nasdaq GlobeNewswire
30/09/2024
Altri  Comunicati